Duoprost

Specialisation

Glaucoma.

Full title

Phase III: Assessment of the efficacy and safety of a fixed combination of unpreserved latanoprost drops and timolol 0.5% (T2347) versus Xalacom® in patients with ocular hypertension or glaucoma.

Promoter

Théa

Start date

March 2015

End date

May 2016

Researchers

Principal: Dr Elena Arrondo